Symposium BM3, Biomaterials for Regenerative Medicine

1638492-WeiNSF已经作出了旅行和注册费的支持本科生，研究生，博士后，和代表性不足，女性和初级教师出席并出席在秋季材料研究学会（MRS）在波士顿，MA，2016年11月28日至30日全国会议上的“生物材料组织再生”研讨会的奖励。研讨会将讨论用于再生医学的生物材料的发展的最新进展。 将涉及的主题包括：1）递送生物制剂以促进组织再生; 2）作为细胞递送载体的生物材料; 3）作为组织工程支架的生物材料; 4）调节免疫反应的生物材料; 5）体内应用的生物材料评估; 6）影响细胞相互作用的生物材料设计; 7）用于再生医学的高通量生物材料筛选和测试; 8）用于研究生物材料-细胞相互作用的新型成像技术;和9）用于再生医学的生物材料的商业化。虽然深入的讨论将考虑组织工程支架，干细胞和生长因子，重点将放在支架和改善支架设计和开发及其在体外和体内的性能。 更广泛的影响将实现与研究生，博士后研究人员和初级教师，特别是从代表性不足的群体可能通过NSF的资金的可用性更大的出席。 组委会将在摘要审查中选择高质量的学生和博士后贡献。

1638492-WeiNSF has made an award in support of travel and registration fees for undergraduate students, graduate students, post-docs, and under-represented, female and junior faculty to attend and present at the symposium on "Biomaterials for Tissue Regeneration" at the Fall Materials Research Society (MRS) national meeting in Boston, MA, November 28-30, 2016. The symposium will address recent advances in the development of biomaterials used for regenerative medicine. Topics to be addressed include: 1) delivery of bioagents to promote tissue regeneration; 2) biomaterials as cell delivery vehicles; 3) biomaterials as tissue engineering scaffolds; 4) biomaterials to modulate immune responses; 5) evaluation of biomaterials for in vivo applications; 6) biomaterial design to influence cell interactions; 7) high throughput biomaterial screening and testing for regenerative medicine; 8) novel imaging techniques for studies of biomaterial-cell interactions; and 9) commercialization of biomaterials for regenerative medicine. Though in depth discussions will consider tissue engineering scaffolds, stem cells, and growth factors, the focus will be on scaffolds and improving scaffold design and development and their in vitro and in vivo performance. Broader impact will be achieved with a larger attendance by graduate students, postdoc researchers, and junior faculty, especially from the under-represented groups made possible by the availability of NSF funding. The organizing committee will select high-quality student and post-doctoral contributions during abstract review.